According to a release issued by the city-based drug maker, revenues was up by nearly 13 per cent to Rs 637 crore compared to Rs 565 crore during the same quarter in FY18.from Moneycontrol Business News http://bit.ly/2vAzMKS
Subscribe to:
Post Comments (Atom)
-
The value had touched a high of 22% of total market capitalisation of listed firms in June 2009, dropping to a low of 5.1% in September 2020...
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment